Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $13.5000 (-0.37%) ($13.4600 - $13.8000) on Fri. Jan. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.36% (three month average) | RSI | 82 | Latest Price | $13.5000(-0.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.8% a day on average for past five trading days. | Weekly Trend | TGTX advances 6.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(67%) ARKG(60%) IBB(59%) ARKK(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -2.68% in a week (0% probabilities). VIXM(-41%) VXX(-40%) TLT(-8%) UUP(-6%) SHY(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.68% (StdDev 5.36%) | Hourly BBV | 0 () | Intraday Trend | -0.4% | | | |
|
5 Day Moving Average | $13.64(-1.03%) | 10 Day Moving Average | $13.64(-1.03%) | 20 Day Moving Average | $12.57(7.4%) | To recent high | -4.3% | To recent low | 135.6% | Market Cap | $1.71b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |